Glaucoma Today

Glaucoma Today Glaucoma Today delivers information on recent research, surgical techniques, clinical strategies, therapeutics, and technology. A BMC Vision publication.

GT offers readers balanced coverage of the topics that matter most! Glaucoma Today is mailed bimonthly (six times a year) to 11,121 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. The publication profiles leaders in the field of glaucoma, and contributing authors present challenging cases as a source of education for readers. Glaucoma Tod

ay delivers balanced coverage of the topics that matter most. Twitter: https://twitter.com/GlaucomaToday
Instagram: https://www.instagram.com/glaucomatoday/

The first International Glaucoma Symposium will be held by Heidelberg Engineering in conjunction with Mainz University o...
01/22/2025

The first International Glaucoma Symposium will be held by Heidelberg Engineering in conjunction with Mainz University on February 1, 2025:

The first International Glaucoma Symposium will be held by Heidelberg Engineering in conjunction with Mainz University on February 1, 2025. Bringin

01/15/2025

In this video, Eric Rosenberg, DO, MScEng, showcases how technology can augment surgical procedures such as MIGS in real-world applications. He demonstrates how visualization with Ngenuity (Alcon) provides a clear view of the angle structures during iStent Infinite (Glaukos) implantation. Continue watching here: https://bit.ly/4gViPjc

Bausch + Lomb announced two seperate deals to acquire early- and mid-stage therapeutic assets.First, B+L, through an aff...
01/13/2025

Bausch + Lomb announced two seperate deals to acquire early- and mid-stage therapeutic assets.

First, B+L, through an affiliate, acquired Whitecap Biosciences LLC, which is currently developing two therapies for potential use in glaucoma and geographic atrophy (GA). Financial tems of the deal were not disclosed. Continue reading here: https://bit.ly/3WjzvZv

01/07/2025

Start the year strong with the latest issue of GT: "Drug Delivery – New Takes on a Longtime Challenge in Care." Explore it now at glaucomatoday.com.

👁️ January is National Glaucoma Awareness Month!Glaucoma is a leading cause of vision loss, affecting millions worldwide...
01/03/2025

👁️ January is National Glaucoma Awareness Month!

Glaucoma is a leading cause of vision loss, affecting millions worldwide—but early detection can make all the difference. Join us in spreading awareness, sharing knowledge, and prioritizing eye health.

💡 Stay informed. Get screened. Protect your sight.

01/02/2025

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Lorraine M. Provencher, MD, and Brian Shafer, MD, to review a real case from his practice.

They discuss details of the case, including patient risk factors and possible treatment goals, and weigh their options for managing the case in the most effective manner while still leaving options on the table for future treatment.

Later, the panelists find out how their colleagues would manage the case, based on results of a social media poll of GT’s audience. Listen in here: https://bit.ly/3P9854n

As part of January’s National Glaucoma Awareness Month, the non-profit Prevent Blindness is offering free educational re...
01/02/2025

As part of January’s National Glaucoma Awareness Month, the non-profit Prevent Blindness is offering free educational resources to patients, care partners, and professionals:

As part of January’s National Glaucoma Awareness Month, the non-profit Prevent Blindness is offering free educational resources to pat

University of Connecticut scientists have published a report in the September issue of Experimental Neurology, showing i...
12/30/2024

University of Connecticut scientists have published a report in the September issue of Experimental Neurology, showing injured optic nerves can regrow towards the brain if treated properly: https://bit.ly/3DCAEVo

12/26/2024

What is the impact of benzalkonium chloride on the long-term health of the eye? According to Jason Bacharach, MD, there are implications beyond just the impact on the ocular surface: https://bit.ly/3BAXn3E

In this article commemorating 75 years of innovation at  , learn more about the company’s investment in R&D of different...
12/23/2024

In this article commemorating 75 years of innovation at , learn more about the company’s investment in R&D of different sustained-release platforms and medications, and surgical treatments that may help reduce patients’ reliance on medications. https://bit.ly/3ZGb754

12/17/2024

I. Paul Singh, MD, shares this teaching video to help other surgeons understand how to address the nasal trabecular meshwork using the OMNI Surgical System (Sight Sciences).

Financial Disclosure: Consultant (Sight Sciences): https://bit.ly/49JTvtR

Learn where the MINIject supraciliary MIGS device fits into Dr. I. Paul Singh’s glaucoma treatment paradigm. He discusse...
12/10/2024

Learn where the MINIject supraciliary MIGS device fits into Dr. I. Paul Singh’s glaucoma treatment paradigm. He discusses the device’s safety and efficacy and shares his clinical experience. Watch here: https://bit.ly/4imp1lk

MINIject is an investigational device in the US and not for sale.

ViaLase announced a research partnership with the John A. Moran Eye Center at the University of Utah (Moran Eye Center),...
12/10/2024

ViaLase announced a research partnership with the John A. Moran Eye Center at the University of Utah (Moran Eye Center), home to the Alan S. Crandall Center for Glaucoma Innovation (Crandall Center). The collaboration will explore aqueous outflow dynamics of ViaLase’s ViaLase laser procedure, utilizing Moran’s iPerfusion technology: https://bit.ly/4fbHGNO

12/04/2024

Austin Bohner, MD, and Craig Chaya, MD, present their preferred surgical bleb revision technique they call "excise and mobilize." The technique involves removing necrotic tissue and advancing healthy conjunctiva.

They say this approach preserves the flap filtration architecture and it is imperative to use a sharp instrument to facilitate the dissection plane. If inadequate conjunctiva remains for closure, shunt removal and patch grafting may be necessary. Continue watching here: https://bit.ly/3D9wF2d

12/02/2024

This episode features two articles recently published in Glaucoma Today. First, Shannan Moore, BS, recaps her article—“Is There a Link Between Chronic Stress, Autonomic Dysregulation, and Glaucomatous Progression?”—which was written with Garrick Chak, MD, and makes the case that it may be worthwhile to incorporate questions about chronic emotional stressors into patient encounters.

Then, Mona Kaleem, MD, recaps her article—“Advances in Eye Drop Aids”—which was written with Delcora Huggins, BS, and reviews four available solutions to help overcome the challenges associated with eye drop administration. Listen on here: https://bit.ly/3OAddyb

11/26/2024

Dr. Manjool Shah discusses a complicated case in which a patient implanted with a Xen Gel Stent experienced an IOP spike after 6 months. Dr. Shah describes his approach to the revision of the Xen and implantation of an Ahmed Glaucoma Valve. Watch: https://bit.ly/3CCinqB

11/21/2024

In this episode, Dr. Nishani Amerasinghe reviews 5-year data behind Hydrus Microstent implantation, sharing insights into insertion techniques to help shorten the learning curve and improve visualization during the procedure. Watch here: https://bit.ly/495JW7Z

11/15/2024

To set clear expectations for patients, surgeons rely on clinical trial data to support treatment decisions. In this article, Dr. Inder Paul Singh reviews the data behind the iDose TR and explains how it can help reduce a patient’s drop burden. Read here: https://bit.ly/4hTUCL9

Address

Wayne, PA

Alerts

Be the first to know and let us send you an email when Glaucoma Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Glaucoma Today:

Videos

Share

Category